Capstone Investment Advisors »

Iovance Biotherapeutics shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $169k 21k 8.13
2023-09-30 $130k 29k 4.55
2023-06-30 $108k 15k 7.04

More positions owned by Capstone Investment Advisors

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Put Option (MSFT)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Meta Platforms Cl A Put Option (META)
Amazon Call Option (AMZN)
Apple Put Option (AAPL)
Tesla Motors Put Option (TSLA)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Select Sector Spdr Tr Financial Call Option (XLF)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Broadcom (AVGO)

View all positions for Capstone Investment Advisors

Top funds holding Iovance Biotherapeutics

Vanguard Group
MHR Fund Management
Perceptive Advisors
venBio Select Advisor
Artisan Partners Limited Partnership
OrbiMed Advisors
Susquehanna International
Balyasny Asset Management
Goldman Sachs Group
Dimensional Fund Advisors
T. Rowe Price Associates
Jpmorgan Chase & Co
Credit Suisse
Long Focus Capital Management
Palo Alto Investors

View all funds holding Iovance Biotherapeutics